Chetter I C, Spark J I, Scott D J, Kester R C
Department of Vascular and Endovascular Surgery, St. James's and Seacroft University Hospitals, Leeds, UK.
Ann Vasc Surg. 1999 Jan;13(1):93-103. doi: 10.1007/s100169900226.
This study aims to analyze the impact of percutaneous transluminal angioplasty (PTA) for claudication on patients' quality of life (QOL). The patients in this study included 108 claudicants, 74 men and 34 women, with a median age of 67 years (range 40-87 years), who were assessed prior to and at 1, 3, and 6 months following PTA. This is the first report to demonstrate that the previously well-documented improvements in the clinical indicators of lower-limb ischemia are accompanied by improvements in individual QOL domains and in overall global QOL. These findings are detectable within a month following PTA and last at least 6 months. The results of this study may go some way to provide proof of efficacy for the procedure and thus help justify the recently questioned widespread use of PTA in clinical practice.
本研究旨在分析经皮腔内血管成形术（PTA）治疗跛行对患者生活质量（QOL）的影响。本研究中的患者包括108名跛行患者，其中74名男性和34名女性，中位年龄为67岁（范围40 - 87岁），在PTA术前以及术后1、3和6个月进行评估。这是第一份报告，表明先前有充分记录的下肢缺血临床指标改善伴随着个体生活质量领域和整体总体生活质量的改善。这些发现可在PTA术后一个月内检测到，并至少持续6个月。本研究结果可能在一定程度上为该手术的疗效提供证据，从而有助于证明近期临床实践中受到质疑的PTA广泛应用的合理性。
